MANAGEMENT OF HIGH-DOSE MELPHALAN-INDUCED ORAL MUCOSITIS: OUR EXPERIENCE

被引：0
|
作者：
Tartarone, Alfredo [1 ]
Matera, Rosella [1 ]
Iodice, Giovanni [1 ]
Romano, Gianpiero [1 ]
Coccaro, Maria [1 ]
Capobianco, Alba [1 ]
Bochicchio, Annamaria [1 ]
Vigliotti, Maria Luigia [1 ]
Mele, Giuseppe [1 ]
Di Leo, Pasquale [1 ]
Musto, Clelia [1 ]
Di Renzo, Nicola [1 ]
机构：
[1] Ctr Riferimento Oncol Basilicata, Div Oncoematol, Rionero In Vulture, PZ, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [41] Amifostine can reduce oral mucositis after high-dose melphalan conditioning in patients with multiple myeloma: A retrospective study.
    Italiano, A
    Chamorey, E
    Foa, C
    Peyrade, F
    Otto, J
    Thyss, A
    BLOOD, 2004, 104 (11) : 338B - 338B
  • [42] Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa
    Marcussen, Mette
    Bodker, Julie Stove
    Christensen, Heidi Sogaard
    Johansen, Preben
    Nielsen, Soren
    Christiansen, Ilse
    Bergmann, Olav Jonas
    Bogsted, Martin
    Dybkaer, Karen
    Vyberg, Mogens
    Johnsen, Hans Erik
    PLOS ONE, 2017, 12 (01):
  • [43] Increased Plasma-Immune Cytokines throughout the High-Dose Melphalan-Induced Lymphodepletion in Patients with Multiple Myeloma: A Window for Adoptive Immunotherapy
    Condomines, Maud
    Veyrune, Jean-Luc
    Larroque, Marion
    Quittet, Philippe
    Latry, Pascal
    Lugagne, Cecile
    Hertogh, Catherine
    Kanouni, Tarik
    Rossi, Jean-Francois
    Klein, Bernard
    JOURNAL OF IMMUNOLOGY, 2010, 184 (02): : 1079 - 1084
  • [44] PHARMACOKINETICS OF VERY HIGH-DOSE ORAL MELPHALAN IN CANCER-PATIENTS
    BOROS, L
    PENG, YM
    ALBERTS, DS
    ASBURY, RF
    GOODMAN, TL
    PENN, TE
    HICKOX, DE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (01): : 19 - 22
  • [45] HIGH-DOSE MELPHALAN FOR REFRACTORY MYELOMA - THE MD-ANDERSON EXPERIENCE
    BARLOGIE, B
    DICKE, KA
    ALEXANIAN, R
    HEMATOLOGICAL ONCOLOGY, 1988, 6 (02) : 167 - 172
  • [46] Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma
    Batlle, Montserrat
    Morgades, Mireia
    Vives, Susana
    Ferra, Christelle
    Oriol, Albert
    Sancho, Juan-Manuel
    Xicoy, Blanca
    Moreno, Miriam
    Magallon, Laura
    Ribera, Josep-Maria
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) : 487 - 491
  • [47] Impact of oral mucositis on outcomes of multiple myeloma patients treated with high-dose melphalan conditioning and autologous stem cell transplantation (ASCT).
    Jaguar, Graziella Chagas
    Rodrigues, Gustavo Henrique
    Guollo, Andre
    Camandoni, Vanessa Oliveira
    Magalhaes, Leila Maria
    Melo, Pessoa
    Alves, Fabio Abreu
    Cordeiro Lima, Vladmir Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [48] Pharmacodynamics of High-Dose Melphalan in Myeloma
    Nath, C. E.
    Joshua, D.
    Kerridge, I.
    Kwan, Y. L.
    Shaw, P. J.
    Trotman, J.
    Zeng, L.
    Presgrave, P.
    Tiley, C.
    McLachlan, A.
    Gurney, H.
    Earl, J.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S34 - S35
  • [49] Encephalopathy complicating high-dose melphalan
    A Schuh
    J Dandridge
    P Haydon
    TJ Littlewood
    Bone Marrow Transplantation, 1999, 24 : 1141 - 1143
  • [50] Clinical Risk Factors for High-Dose Methotrexate-Induced Oral Mucositis Following Individualized Dosing
    Hu, Zhongbo
    Escalera-Joy, Andrea M.
    Ashcraft, Emily
    Acharya, Rushil
    Jeha, Sima
    Cheng, Cheng
    Pui, Ching-Hon
    CANCER MEDICINE, 2024, 13 (21):
12345